DCF, I hear what you say. I follow the daily reports and Flanders (Belgium) has 90+% vaccination, incl. now 5-12y olds starting to get injected. Furthermore we are finishing the 3rd burst injection in February.
So it might be different, but while the infections go up, the intensive care and deaths are dropping rapidly. It was now confirms 5 days in a row. Furthermore 90% of the people ending up in the hospital are still Delta infected ones. More then 90% are people that where either not vaccinated and people that had prior conditions impacting their immune system.
Apparently and unfortunately, in the field, Omicron doesn't push the more dangerous Delta aside 100%. The ratio seems to be 85/15.
About the approval.
Maybe one shouldn't make the same mistake with possible approvals of Lenz outside the US as they did with the approval of Lenz in the US.
Months ago everyone was posting about the approval of Lenz in the US being just behind the corner. Yet, there wasn't anything behind the corner (but their could have been).
The same thing is true, IMO, for UK, Korea or other potential approvals. Maybe one should talk about the possible approvals in UK, rather then of the approvals as if they were certain. If they were the pro's would have known already and this stock would not be where it is now.
AIMO
News 
Market Data 
Discover 
